132 related articles for article (PubMed ID: 10725961)
1. History of the development of antiemetic guidelines at Mayo Clinic Rochester.
Loprinzi CL; Alberts SR; Christensen BJ; Hanson LJ; Farley DR; Broers JK; Betcher DL; Grady RE; Southorn PA; Johnson TM; Perez EA
Mayo Clin Proc; 2000 Mar; 75(3):303-9. PubMed ID: 10725961
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and cost effectiveness of new antiemetic guidelines.
Engstrom C; Hernandez I; Haywood J; Lilenbaum R
Oncol Nurs Forum; 1999 Oct; 26(9):1453-8. PubMed ID: 11064877
[TBL] [Abstract][Full Text] [Related]
3. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
Trigg ME; Higa GM
J Oncol Pharm Pract; 2010 Dec; 16(4):233-44. PubMed ID: 20085961
[TBL] [Abstract][Full Text] [Related]
5. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
Trigg ME; Inverso DM
Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
[TBL] [Abstract][Full Text] [Related]
6. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
Herrstedt J
Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
[TBL] [Abstract][Full Text] [Related]
7. Management of nausea and vomiting caused by anticancer drugs: state of the art.
Pisters KM; Kris MG
Oncology (Williston Park); 1992 Feb; 6(2 Suppl):99-104. PubMed ID: 1532744
[TBL] [Abstract][Full Text] [Related]
8. Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
Nolte MJ; Berkery R; Pizzo B; Baltzer L; Grossano D; Lucarelli CD; Kris MG
J Clin Oncol; 1998 Feb; 16(2):771-8. PubMed ID: 9469369
[TBL] [Abstract][Full Text] [Related]
9. Integrating aprepitant and palonosetron into clinical practice: a role for the new antiemetics.
Viale PH
Clin J Oncol Nurs; 2005 Feb; 9(1):77-84. PubMed ID: 15751501
[TBL] [Abstract][Full Text] [Related]
10. Economic impact of antiemesis.
Grunberg SM
Oncology (Williston Park); 1995 Nov; 9(11 Suppl):155-60. PubMed ID: 8608047
[TBL] [Abstract][Full Text] [Related]
11. Clinical practice guidelines on antiemetics in oncology.
Aranda Aguilar E; Constenla Figueiras M; Cortes-Funes H; Diaz-Rubio García E; Gascon Vilaplana P; Guillém V; Martin-Algarra S
Expert Rev Anticancer Ther; 2005 Dec; 5(6):963-72. PubMed ID: 16336087
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
Jordan K; Kasper C; Schmoll HJ
Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment--how are we doing?
Grunberg SM
J Support Oncol; 2004; 2(1 Suppl 1):1-10, inside back cover; quiz 11. PubMed ID: 16117016
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
Goodman M
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting].
Durand JP; Madelaine I; Scotté F
Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117
[TBL] [Abstract][Full Text] [Related]
16. Anti-emetic therapy in cancer chemotherapy: current status.
Herrstedt J; Dombernowsky P
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic research: future directions.
Olver I; Molassiotis A; Aapro M; Herrstedt J; Grunberg S; Morrow G
Support Care Cancer; 2011 Mar; 19 Suppl 1():S49-55. PubMed ID: 21063733
[TBL] [Abstract][Full Text] [Related]
18. Best practice management of CINV in oncology patients: II. Antiemetic guidelines and rationale for use.
Wickham R
J Support Oncol; 2010; 8(2 Suppl 1):10-5. PubMed ID: 20629453
[TBL] [Abstract][Full Text] [Related]
19. Cost-reducing treatment algorithms for antineoplastic drug-induced nausea and vomiting.
Berard CM; Mahoney CD
Am J Health Syst Pharm; 1995 Sep; 52(17):1879-85. PubMed ID: 8528849
[TBL] [Abstract][Full Text] [Related]
20. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
Egan AP; Taggart JR; Bender CM
Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
